Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis

Published:2021-06-02 Issue:8 Volume:40 Page:3185-3193
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Ma Xinyu,Tang Rui,Luo Mei,Zeng Zhuotong,Shi Yaqian,Tang Bingsi,Xiao Rong

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-021-05794-5.pdf

Reference26 articles.

1. Brown M, O’Reilly S (2019) The immunopathogenesis of fibrosis in systemic sclerosis. Clin Exp Immunol 195(3):310–321. https://doi.org/10.1111/cei.13238

2. Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685–1699. https://doi.org/10.1016/S0140-6736(17)30933-9

3. Allanore Y, Simms R, Distler O et al (2015) Systemic sclerosis. Nat Rev Dis Prim 1(April 2015). https://doi.org/10.1038/nrdp.2015.2

4. Poudel DR, Derk CT (2018) Mortality and survival in systemic sclerosis: a review of recent literature. Curr Opin Rheumatol 30(6):588–593. https://doi.org/10.1097/BOR.0000000000000551

5. Cottin V, Brown KK (2019) Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res 20(1):1–10. https://doi.org/10.1186/s12931-019-0980-7

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis;Seminars in Arthritis and Rheumatism;2024-10

2. Efficacy of Rituximab Versus Cyclophosphamide and Mycophenolate for the Treatment of Interstitial Lung Disease in Systemic Sclerosis: A Systematic Review;Cureus;2024-08-31

3. Efficacy and safety of mycophenolate mofetil versus cyclophosphamide therapy for Henoch schonlein purpura nephritis in children: A meta-analysis;Medicine;2024-07-26

4. A Review of Myositis-Associated Interstitial Lung Disease;Journal of Clinical Medicine;2024-07-11

5. Absence of interstitial lung disease at initial visit may predict a favorable outcome for Japanese patients with systemic sclerosis with anti–topoisomerase I antibody;The Journal of Dermatology;2023-10-21